Literature DB >> 19275737

Uptake and dynamics of infectious prion protein in the intestine.

Yasuhisa Ano1, Akikazu Sakudo, Hiroyuki Nakayama, Takashi Onodera.   

Abstract

Transmissible spongiform encephalopathies (TSEs) are characterized by the accumulation of a protease-resistant abnormal isoform of the prion protein (PrPSc), which is converted from the cellular isoform of the prion protein (PrPC). In the oral transmission of prion protein, PrPSc can invade a host body through the intestinal tract. There is only limited information available on how the infectious agent passes through one or several biological barriers before it can finally reach the brain. After oral administration, PrPSc withstands the digestive process and may be incorporated by microfold (M) cells or villous columnar epithelial cells in the intestine. After entry into the intestinal epithelium, PrPSc accumulates and is amplified in follicular dendritic cells (FDCs) within Peyer's patches and other isolated lymphoid follicles possibly by an interaction with dendritic cells or macrophages. Following accumulation in gut-associated lymphoid tissues, PrPSc is thought to move to the enteric nervous systems (ENS) by an interaction with FDCs or dendritic cells. As a result of neuroinvasion into the ENS, PrPSc spreads to the central nervous system. In addition, an epidemiological study suggested that most bovine spongiform encephalopathy cases had been exposed to the agent in the first 6 months of life. Developments of the intestinal defense and immune system may be involved in the susceptibility to infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275737     DOI: 10.2174/092986609787601642

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  8 in total

Review 1.  Transmission of prions within the gut and towards the central nervous system.

Authors:  Gianfranco Natale; Michela Ferrucci; Gloria Lazzeri; Antonio Paparelli; Francesco Fornai
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

Review 2.  Emerging roles for enteric glia in gastrointestinal disorders.

Authors:  Keith A Sharkey
Journal:  J Clin Invest       Date:  2015-02-17       Impact factor: 14.808

3.  Monitoring immune cells trafficking fluorescent prion rods hours after intraperitoneal infection.

Authors:  Theodore E Johnson; Brady A Michel; Crystal Meyerett; Angela Duffy; Anne Avery; Steven Dow; Mark D Zabel
Journal:  J Vis Exp       Date:  2010-11-19       Impact factor: 1.355

4.  Evidence for varied aetiologies regulating the transmission of prion disease: implications for understanding the heritable basis of prion incubation times.

Authors:  Conrad O Iyegbe; Oduola O Abiola; Chris Towlson; John F Powell; Steven A Whatley
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

5.  Prion uptake in the gut: identification of the first uptake and replication sites.

Authors:  Pekka Kujala; Claudine R Raymond; Martijn Romeijn; Susan F Godsave; Sander I van Kasteren; Holger Wille; Stanley B Prusiner; Neil A Mabbott; Peter J Peters
Journal:  PLoS Pathog       Date:  2011-12-22       Impact factor: 6.823

6.  Impaired Cellular Immunity in the Murine Neural Crest Conditional Deletion of Endothelin Receptor-B Model of Hirschsprung's Disease.

Authors:  Ankush Gosain; Amanda J Barlow-Anacker; Chris S Erickson; Joseph F Pierre; Aaron F Heneghan; Miles L Epstein; Kenneth A Kudsk
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

Review 7.  Nutrient Sensing via Gut in Drosophila melanogaster.

Authors:  Gouri Chopra; Shivam Kaushik; Pinky Kain
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

Review 8.  The Effects of Immune System Modulation on Prion Disease Susceptibility and Pathogenesis.

Authors:  Neil A Mabbott; Barry M Bradford; Reiss Pal; Rachel Young; David S Donaldson
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.